Search research articles
Contact Us
Filters
Showing results (101-110 of 154) with videos related to
Page
of 16
Sort By:
Acta Gastro-Enterologica Belgica
|
January 1, 1995
Duodenogastric reflux, histology and cell proliferation of the gastric mucosa before and six months after cholecystectomy
D Lorusso, F Pezzolla, M Linsalata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2007
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
G Ferrandina, M Ludovisi, R De Vincenzo, et al.
Cancer Treatment Reviews
|
October 11, 2021
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors
M Bartoletti, L Musacchio, G Giannone, et al.
Scandinavian Journal of Gastroenterology
|
March 1, 2003
Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation
M G Caruso, M Notarnicola, M Bifulco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2003
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients
D Lorusso, G Ferrandina, S Greggi, et al.
Gynecologic Oncology
|
July 25, 2020
Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study
D Lorusso, C Marchetti, C Conte, et al.
Cancer Chemotherapy and Pharmacology
|
September 13, 2011
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy
S Pignata, F Amant, G Scambia, et al.
British Journal of Cancer
|
June 13, 2013
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary
G Mangili, J Ottolina, A Gadducci, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 16, 2012
Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study
F Zanaboni, B Grijuela, S Giudici, et al.
Critical Reviews in Oncology/Hematology
|
March 19, 2025
Management of early-stage ovarian cancer: Open questions and debated issues
V Salutari, E Giudice, E Rapisarda, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 154) with videos related to
Sort By:
Page
of 16
Acta Gastro-Enterologica Belgica
|
January 1, 1995
Duodenogastric reflux, histology and cell proliferation of the gastric mucosa before and six months after cholecystectomy
D Lorusso, F Pezzolla, M Linsalata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2007
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
G Ferrandina, M Ludovisi, R De Vincenzo, et al.
Cancer Treatment Reviews
|
October 11, 2021
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors
M Bartoletti, L Musacchio, G Giannone, et al.
Scandinavian Journal of Gastroenterology
|
March 1, 2003
Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation
M G Caruso, M Notarnicola, M Bifulco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2003
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients
D Lorusso, G Ferrandina, S Greggi, et al.
Gynecologic Oncology
|
July 25, 2020
Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study
D Lorusso, C Marchetti, C Conte, et al.
Cancer Chemotherapy and Pharmacology
|
September 13, 2011
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy
S Pignata, F Amant, G Scambia, et al.
British Journal of Cancer
|
June 13, 2013
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary
G Mangili, J Ottolina, A Gadducci, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 16, 2012
Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study
F Zanaboni, B Grijuela, S Giudici, et al.
Critical Reviews in Oncology/Hematology
|
March 19, 2025
Management of early-stage ovarian cancer: Open questions and debated issues
V Salutari, E Giudice, E Rapisarda, et al.
Page
of 16